Certified by Founder Lodge 
                                        
                                        Modifi Bio
 
                                                 United States  -  New Haven, Connecticut 
                                             START UP 
                                                                                    1 Disclosed Funding Rounds $4,300,000
                                            0 Participating Investments
- 
                                                Founded date 
                                                
2021
 - 
                                                Operating Status 
                                                
Active
 - 
                                                Last Funding Type 
                                                
Seed
 - 
                                                Company Type 
                                                
For Profit
 - Website
 - Contact
 - Social Links
 
                                            A bold and innovative biotech, Modifi Bio is developing a novel oncology therapeutics platform that exploits DNA defects in a wide range of cancer cells, and which aims to disrupt conventiona
                                        
                                        
                                        
                                                                                
                                        
                                                                                | Date | Round | Raised | Participating Investors | 
|---|---|---|---|
| October, 17 ,2023 | Seed | $4,300,000 | 
                                                
 BrightEdge
                                                                                
 Connecticut Innovations
                                                                                
 Advantage Capital
                                                                                
 HighCape Capital
                                                                                
 Pathway Bioventures
                                                                                
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
                                                                        
                                Helex |  $3,500,000  | (Nov 4, 2025)
                                                                        
                                xMEMS |  $21,000,000  | (Nov 4, 2025)
                                                                        
                                catalyx space |  $5,400,000  | (Nov 4, 2025)
                                                                        
                                Cephia AI |  $4,000,000  | (Nov 4, 2025)
                                                                        
                                Ornn |  $5,700,000  | (Nov 4, 2025)